
PHD position
(opening soon)
Regulation of stress by the gut microbiome
Using a one health approach, this PhD project tackles the fundamental scientific challenge of elucidating the relationship between the gut microbiota and stress. This project is a collaboration between the Cisneros and the Arnott labs at QUB that leverages the structural and functional similarities between humans and monogastric animals. By integrating molecular profiling with advanced in vitro and in vivo models, the research aims to investigate the regulatory signalling pathways responsible for promoting stress resilience. The goal is the discovery of novel, highly translatable therapeutic targets applicable across humans and a wide variety of animals.
About the labs:
The Cisneros lab studies the gut microbiome and how it influences human health. Our goal is to integrate the newest technologies with classical molecular genetics to understand how the gut microbiome is established and how it can cause disease when this process goes wrong. Get more detailed information about the lab here: www.cisneros-lab.org
The Arnott lab studies behavioural biology in a range of species. The research spans from fundamental behavioural ecology through to applied animal welfare relevance. This includes examining interactions between physiology, the microbiome and animal behaviour.
About our philosophy:
Our research approach is based on a people-centric view of the scientific endeavour (see link). To help these aims, the Wellcome-Wolfson institute for Experimental Medicine and the School of Biological Sciences count with state-of-the-art facilities, with an integrative view of health. Moreover, QUB excels on equality and diversity charters (race and gender).
About the project:
Trillions of bacteria comprise the gut microbiome and contribute to human health by producing metabolites that regulate intestinal health and contribute to homeostasis. Therefore, the microbiome represents an innovative approach to develop new therapies. Our team studies prominent members of the gut microbiome with therapeutic potential.
It is poorly understood at the molecular level how the gut microbiome exerts influence over systemic health. In this project, we will study microbial signals that bridge the gut and systemic physiological axes. The results of this research will contribute to design interventions to reduce stress and improve metabolic homeostasis.
The successful candidate will acquire training in advanced cell biology (organoids), microbiology, transcriptomics, and in vivo models. The project should provide experience to pursue industrial or academic R&D in the field of microbiome therapeutic biologicals, synthetic biology, or biotechnology.
Requirements:
Candidates should have experience with cell culture techniques and good knowledge of microbiological and molecular biology techniques. Microbiome sequencing experience will be considered a plus.
Opening time: PhD position opening in December 2026.
Starting time: October 2027
Place: Queen’s University Belfast
Stay tuned in findaphd.com or get in contact.